Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation

Historically, the effort by academia and industry to develop new chemical entities into lifesaving drugs has limited success in meeting the demands of today’s healthcare. Repurposing drugs that are originally approved by the United States Food and Drug Administration or by regulatory authorities aro...

Full description

Bibliographic Details
Main Authors: Shraddha M. Dalwadi, Andrew Hunt, Mark D. Bonnen, Yohannes T. Ghebre
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1198284/full